Company
United StatesKBI Biopharma, Inc., Boulder, CO – FDA Inspections
Inspection records and compliance data for KBI Biopharma, Inc. in Boulder, Colorado. 3 FDA inspections on record, 2 Form 483s, last inspected December 03, 2021.
Company Profile
This profile covers KBI Biopharma, Inc. based in Boulder, Colorado, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Unclassified
- 2
- Form 483s
- 2
- Warning letters
- 0
First inspected December 9, 2016. Last inspected December 3, 2021.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 3, 2021 | VAI | Human Drugs · Drug Quality Assurance | 1158021 |
| September 12, 2018 | Not classified | Human Drugs | 1066025 |
| December 9, 2016 | Not classified | Human Drugs | 994318 |
FDA documents
Other regulators (1)
People (5)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Kyowa Kirin Co., Ltd.
Chugai Pharma Manufacturing Co. Ltd. (CPMC)
Zydus Lifesciences Limited
PharmaEssentia Corporation, Taichung Plant
Wuxi Biologics Co Ltd
Daito Pharmaceutical Co., Ltd.
WuXi Biologics Ireland Limited
ANTHEM BIOSCIENCES PRIVATE LIMITED - Phase II
Regeneron Ireland Designated Activity Company
FUJIFILM Diosynth Biotechnologies Texas, LLC
Company Information
Name
KBI Biopharma, Inc.
FEI Number
3011326133
Address
2500 Central Ave, Boulder, Colorado 80301, United States
Country
United States
ID: 0116f415-95dd-4a3f-a854-182d0314d5a5